Dr. Vishy Chebrol is a seasoned healthcare investor and operator with deep experience in injectables and pharmaceutical platforms. He currently serves as CEO of Sagent Pharmaceuticals, where he is leading the company’s transformation following its acquisition in 2023. His experience spans control investing, platform building, and operational transformation across global regulated markets — combining the credibility of an operator with the rigour of an investor.